Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) shares reached a new 52-week low during trading on Monday . The ...
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have been given a consensus recommendation of “Buy” by the ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), ...
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases ...
Oruka Therapeutics, Inc. (NASDAQ:ORKA), a biopharmaceutical company with a market capitalization of $753 million and strong financial health according to InvestingPro analysis, has entered into a ...
Oruka Therapeutics, Inc. (NASDAQ:ORKA), a biopharmaceutical company with a market capitalization of $753 million and strong financial health according to InvestingPro analysis, has entered into a ...
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback